Published
AstraZeneca is powering modern #machinelearning (ML) and AI to accelerate drug discovery with Cambridge-1, training models to learn the grammar of chemistry, and processing whole slide digital pathology images.
Learn more about #healthcare and life sciences research on NVIDIA Cambridge-1: https://nvda.ws/3yPKmf1
Learn more about #healthcare and life sciences research on NVIDIA Cambridge-1: https://nvda.ws/3yPKmf1
- Category
- NVIDIA
- Tags
- NVIDIA, AI, machinelearning
Be the first to comment
Up Next
Autoplay
-
02:51
BenevolentAI – Accelerating Scientific Discovery With AI
-
36:02
NVIDIA Special Address at ISC22: Accelerating AI Innovation and Scientific Discovery
-
02:24
Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo
-
01:14
NVIDIA and Schrödinger Partner to Accelerate Drug Discovery Worldwide
-
01:39
Harnessing the Scale of Cloud to Accelerate Drug Discovery
-
01:16
End to end Machine Learning pipeline with AMD EPYC 9374F
-
00:40
Drug Discovery Set for Deep Learning Transformation Powered by GPUs
-
02:22
Digital Domain Brings Virtual Humans To Life With Machine Learning
-
04:32
Compute the Cure: Accelerating the Discovery of Drugs to Fight Cancer
-
02:39
Research at NVIDIA: New Core AI and Machine Learning Lab
-
01:31
Interactive Visualization of High-Resolution, Global-Scale Climate Data in the Cloud
-
02:20
Generating Potential Accident Scenarios for Autonomous Vehicles Using AI - NVIDIA DRIVE Labs Ep. 27
-
00:34
NVIDIA GTC 2023 Keynote Teaser
-
02:13
Experience Hospitality Design on CloudXR with AWS
-
1:17:52
GTC 2023 Keynote with NVIDIA CEO Jensen Huang
-
02:48
BMW Group Celebrates Opening the World's First Virtual Factory in NVIDIA Omniverse
-
02:31
NVIDIA Omniverse Foundational Technology Montage I GTC Spring 2023 Edition
-
02:03
Amazon Robotics Deploys First Fully Autonomous Robot With NVIDIA Isaac Sim
-
02:04
Easily Scale and Unify Industrial Digitalization With NVIDIA Omniverse Cloud
-
03:14
I AM AI | NVIDIA GTC 2023 | Official Keynote Intro